Yahoo
Shenzhen - Delayed Quote CNY

Aier Eye Hospital Group Co., Ltd. (300015.SZ)

8.68 +0.16 (+1.88%)
At close: 3:04:25 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
23,213,033.59
22,352,604.72
20,982,894.15
20,367,156.74
16,109,946.69
Cost of Revenue
12,676,656.91
11,821,511.65
10,886,548.80
10,021,974.99
7,980,388.80
Gross Profit
10,536,376.68
10,531,093.08
10,096,345.35
10,345,181.75
8,129,557.88
Operating Expense
5,269,588.99
5,633,607.09
5,309,150.86
4,796,599.52
4,108,876.55
Operating Income
5,266,787.69
4,897,485.98
4,787,194.49
5,548,582.23
4,020,681.33
Net Non Operating Interest Income Expense
-368,855.08
-247,297.91
-203,958.27
-126,039.96
-135,628.37
Pretax Income
4,367,981.93
4,425,135
4,594,282.27
4,551,018.61
3,335,055.55
Tax Provision
1,705,306.63
951,915.79
858,152.58
895,023.07
646,059.02
Net Income Common Stockholders
2,423,240.74
3,240,259.47
3,556,055.83
3,358,871.54
2,524,230.84
Basic EPS
0.26
0.35
0.38
0.36
0.28
Diluted EPS
0.26
0.35
0.38
0.36
0.28
Basic Average Shares
9,307,804.86
9,268,476.73
9,243,711.55
9,217,539.89
9,047,422.37
Diluted Average Shares
9,307,804.86
9,268,476.73
9,243,711.55
9,250,541.27
9,060,412.21
Total Operating Income as Reported
4,690,077.41
4,603,094.87
4,824,917.46
4,947,946.78
3,534,499.52
Rent Expense Supplemental
202,269
199,068.76
184,724.83
133,063.68
94,236.57
Total Expenses
17,946,245.90
17,455,118.74
16,195,699.66
14,818,574.51
12,089,265.35
Net Income from Continuing & Discontinued Operation
2,423,240.74
3,240,259.47
3,556,055.83
3,358,871.54
2,524,230.84
Normalized Income
2,635,492.41
3,392,164.98
3,524,502.44
3,819,609.47
2,948,293.52
Interest Income
55,586.30
72,167.15
96,046.35
119,205.07
87,649.55
Interest Expense
277,839.10
269,717.42
255,561.40
194,823.31
177,647.50
Net Interest Income
-368,855.08
-247,297.91
-203,958.27
-126,039.96
-135,628.37
EBIT
4,645,821.03
4,694,852.43
4,849,843.67
4,745,841.92
3,512,703.05
EBITDA
4,645,821.03
6,473,383.63
6,444,069.01
6,093,040.66
4,678,929.40
Reconciled Cost of Revenue
12,676,656.91
11,821,511.65
10,886,548.80
10,021,974.99
7,980,388.80
Reconciled Depreciation
1,740,796.99
1,778,531.21
1,594,225.34
1,347,198.73
1,166,226.35
Net Income from Continuing Operation Net Minority Interest
2,423,240.74
3,240,259.47
3,556,055.83
3,358,871.54
2,524,230.84
Total Unusual Items Excluding Goodwill
-348,187.95
-193,538.73
38,800.90
-573,531.04
-525,948.09
Total Unusual Items
-348,187.95
-193,538.73
38,800.90
-573,531.04
-525,948.09
Normalized EBITDA
4,994,008.98
6,666,922.36
6,405,268.11
6,666,571.70
5,204,877.49
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-135,936.28
-41,633.21
7,247.51
-112,793.10
-101,885.41
12/31/2022 - 10/30/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: